1. Home
  2. Analysis
  3. Ceftriaxone
  4. Halaven

Ceftriaxone and Halaven drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ceftriaxone (ceftriaxone sodium) and Halaven (eribulin mesylate). Common drug interactions include coagulopathy among females.

The phase IV clinical study analyzes what interactions people have when they take Ceftriaxone and Halaven. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Ceftriaxone?

Ceftriaxone has active ingredients of ceftriaxone sodium. It is often used in typhoid fever. eHealthMe is studying from 40,991 Ceftriaxone users. Check the latest studies of Ceftriaxone.

What is Halaven?

Halaven has active ingredients of eribulin mesylate. eHealthMe is studying from 3,881 Halaven users. Check the latest studies of Halaven.

On Jul, 19, 2026

21 people who take Ceftriaxone and Halaven together, and have interactions are studied.

Ceftriaxone and Halaven drug interactions.

What are the common drug interactions of Ceftriaxone and Halaven, by gender? *:

female:

  1. Coagulopathy (blood's ability to clot is impaired)
  2. Neuropathy peripheral (surface nerve damage)
  3. Pseudomonal sepsis (pseudomonas infections are diseases caused by a bacterium from the genus pseudomonas)
  4. Renal failure acute (rapid kidney dysfunction)
  5. Anuria (failure of the kidneys to produce urine)
  6. Febrile neutropenia (fever with reduced white blood cells)
  7. Fluid overload (too much fluid in the blood)
  8. Oedema peripheral (superficial swelling)
  9. Oliguria (not enough urine)
  10. Weight increased

male:

n/a

What are the common drug interactions of Ceftriaxone and Halaven, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Pseudomonal sepsis (pseudomonas infections are diseases caused by a bacterium from the genus pseudomonas)

50-59:

  1. Coagulopathy (blood's ability to clot is impaired)
  2. Neuropathy peripheral (surface nerve damage)

60+:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Renal failure acute (rapid kidney dysfunction)

What are the existing conditions these people have? *

  1. Breast Cancer: 19 people, 90.48%
  2. Thrombosis (formation of a blood clot inside a blood vessel): 18 people, 85.71%
  3. Gastritis (inflammation of stomach): 18 people, 85.71%
  4. Gastric Ulcer (stomach ulcer): 18 people, 85.71%
  5. Folliculitis (infection of hair root): 18 people, 85.71%
  6. Cholecystitis Acute (rapid infection of gallbladder): 18 people, 85.71%
  7. Blepharitis (chronic inflammation of the eyelid): 18 people, 85.71%
  8. Biliary Sepsis: 18 people, 85.71%
  9. Abdominal Pain Upper: 18 people, 85.71%
  10. Abdominal Pain: 18 people, 85.71%

* Approximation only. Some reports may have incomplete information.

Do you take Ceftriaxone and Halaven?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ceftriaxone and Halaven:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ceftriaxone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Halaven:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ceftriaxone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Halaven and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on ceftriaxone sodium and eribulin mesylate (the active ingredients of Ceftriaxone and Halaven, respectively), and Ceftriaxone and Halaven (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.